Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation
Titel:
Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation
Auteur:
Dautzenberg, Lauren Numan, Lieke Knol, Wilma Gianoli, Monica van der Meer, Manon G. Troost-Oppelaar, Anne-Marie Westendorp, Aline F. Emmelot-Vonk, Marielle H. van Laake, Linda W. Koek, Huiberdina L.